Skip to main content
MASIMO CORP logo

MASIMO CORP — Investor Relations & Filings

Ticker · MASI ISIN · US5747951003 LEI · 549300Q4A8JK0PIYCU29 US Manufacturing
Open in API
Filings indexed 1,253 across all filing types
Latest filing 2019-01-07 Board/Management Inform…
Country US United States of America
Listing US MASI

About MASIMO CORP

https://www.masimo.com/

Masimo is a global medical technology company that develops, manufactures, and markets a wide array of noninvasive patient monitoring technologies. The company's core offering is its proprietary Signal Extraction Technology (SET®) pulse oximetry, renowned for its ability to provide accurate measurements during patient motion and low peripheral perfusion. Masimo's product portfolio also includes advanced solutions for brain function monitoring (SedLine®), regional oximetry (O3®), and integrated patient monitoring and connectivity platforms like Root®. These technologies are designed to improve patient outcomes, enhance patient safety, and streamline clinical workflows in various healthcare settings, including hospitals, emergency medical services, and home care. The company focuses on creating innovative solutions that empower clinicians with reliable data to make critical care decisions.

Recent filings

Filing Released Lang Actions
Board/Management Information 2019
Board/Management Information Classification · 100% confidence The document is a Form 8-K Current Report filed with the SEC, dated January 2, 2019. The main content is about the appointment of a new director, Julie A. Shimer, Ph.D., to the Board of Directors of Masimo Corporation. It details her background, compensation, and related agreements. There is no financial data or earnings information, nor is it a full annual or quarterly report. The document fits the category of announcements related to changes in the company's board of directors or senior management. Therefore, it should be classified as Board/Management Information (MANG). The document length is 6290 characters, which is sufficient to contain substantive information about the appointment rather than a brief announcement or a report publication notice.
2019-01-07 English
FORM 4
Director's Dealing
2019-01-04 English
FORM 4
Director's Dealing
2019-01-04 English
FORM 4
Director's Dealing
2019-01-04 English
FORM 4
Director's Dealing
2019-01-04 English
FORM 4
Director's Dealing
2019-01-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.